Geoff Christopher Woods

Geoff Christopher Woods


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2006 in Nature
Verified
Journal Article
Closed access
PDF file
JCJames J. Cox
James J. Cox
FRFrank Reimann
Frank Reimann
ANAdeline K. Nicholas
Adeline K. Nicholas
GTGemma Thornton
Gemma Thornton
EREmma Roberts
Emma Roberts
GWGeoff Christopher Woods
Geoff Christopher Woods

1 November 2009 in Trends in Genetics
Verified
Journal Article
Open access
GTGemma K. Thornton
Gemma K. Thornton
GWGeoff Christopher Woods
Geoff Christopher Woods
The relatively large brain and expanded cerebral cortex of humans is unusual in the animal kingdom and is thought to have promoted our adaptability and success as a species. One approach for investigating neurogenesis is the study of autosomal recessive primary microcephaly (MCPH), in which prenatal brain growth is significantly reduced without an effect on brain structure. To date, eight MCPH loci and five genes have been identified. Unexpectedly, all MCPH proteins are ubiquitous and localise to centrosomes for at least part of the cell cycle. Here, we focus on recent functional studies of MCPH proteins that reveal the centrosome as a final integration point for many regulatory pathways affecting prenatal neurogenesis in mammals.

1 May 2005 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
GWGeoff Christopher Woods
Geoff Christopher Woods
JBJacquelyn Bond
Jacquelyn Bond
WEWolfgang Enard
Wolfgang Enard

3 October 2010 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ANAdeline K Nicholas
Adeline K Nicholas
MKMaryam Khurshid
Maryam Khurshid
JDJulie Désir
Julie Désir
OCOfelia Carvalho
Ofelia Carvalho
JCJames J Cox
James J Cox
GWGeoff Christopher Woods
Geoff Christopher Woods

8 March 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
FRFrank Reimann
Frank Reimann
JCJames J. Cox
James J. Cox
IBInna Belfer
Inna Belfer
LDLuda Diatchenko
Luda Diatchenko
DZDmitri V. Zaykin
Dmitri V. Zaykin
GWGeoff Christopher Woods
Geoff Christopher Woods
The gene SCN9A is responsible for three human pain disorders. Nonsense mutations cause a complete absence of pain, whereas activating mutations cause severe episodic pain in paroxysmal extreme pain disorder and primary erythermalgia. This led us to investigate whether single nucleotide polymorphisms (SNPs) in SCN9A were associated with differing pain perception in the general population. We first genotyped 27 SCN9A SNPs in 578 individuals with a radiographic diagnosis of osteoarthritis and a pain score assessment. A significant association was found between pain score and SNP rs6746030; the rarer A allele was associated with increased pain scores compared to the commoner G allele ( P = 0.016). This SNP was then further genotyped in 195 pain-assessed people with sciatica, 100 amputees with phantom pain, 179 individuals after lumbar discectomy, and 205 individuals with pancreatitis. The combined P value for increased A allele pain was 0.0001 in the five cohorts tested (1277 people in total). The two alleles of the SNP rs6746030 alter the coding sequence of the sodium channel Nav1.7. Each was separately transfected into HEK293 cells and electrophysiologically assessed by patch-clamping. The two alleles showed a difference in the voltage-dependent slow inactivation ( P = 0.042) where the A allele would be predicted to increase Nav1.7 activity. Finally, we genotyped 186 healthy females characterized by their responses to a diverse set of noxious stimuli. The A allele of rs6746030 was associated with an altered pain threshold and the effect mediated through C-fiber activation. We conclude that individuals experience differing amounts of pain, per nociceptive stimulus, on the basis of their SCN9A rs6746030 genotype.

9 October 2011 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JSJoo-Hee Sir
Joo-Hee Sir
ABAlexis R Barr
Alexis R Barr
ANAdeline K Nicholas
Adeline K Nicholas
OCOfelia Carvalho
Ofelia Carvalho
MKMaryam Khurshid
Maryam Khurshid
FGFanni Gergely
Fanni Gergely
Fanni Gergely, Geoffrey Woods and colleagues identify a disease-associated CEP63 mutation in a family with primary microcephaly. They further show that CEP63 and CEP152 interact and form a discrete ring around the proximal end of the parental centriole, implicating this complex in the regulation of centrosome number. Autosomal recessive primary microcephaly (MCPH) is characterized by a substantial reduction in prenatal human brain growth without alteration of the cerebral architecture and is caused by biallelic mutations in genes coding for a subset of centrosomal proteins1,2,3,4,5,6,7,8,9,10. Although at least three of these proteins have been implicated in centrosome duplication11, the nature of the centrosome dysfunction that underlies the neurodevelopmental defect in MCPH is unclear. Here we report a homozygous MCPH-causing mutation in human CEP63. CEP63 forms a complex with another MCPH protein, CEP152, a conserved centrosome duplication factor12,13,14,15. Together, these two proteins are essential for maintaining normal centrosome numbers in cells. Using super-resolution microscopy, we found that CEP63 and CEP152 co-localize in a discrete ring around the proximal end of the parental centriole, a pattern specifically disrupted in CEP63-deficient cells derived from patients with MCPH. This work suggests that the CEP152-CEP63 ring-like structure ensures normal neurodevelopment and that its impairment particularly affects human cerebral cortex growth.